Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.67 +0.07 (+1.94%)
As of: Oct 21, 2026 · 10:14 AM EDT

Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) reported Capital Expenditures of $265,000 for Q2 2026, down 46.8% from $498,000 a year earlier and down 62.8% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bicycle Therapeutics' Capital Expenditures came in at $2.23 million, up 16.9% year-over-year; for FY2025, it came in at $2.35 million, up 90.3% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $1.24 million in FY2024 (-57.8%), $2.93 million in FY2023 (-84.6%), $18.99 million in FY2022 (+835.3%) and $2.03 million in FY2021 (+69.2%).
  • The Q2 2026 figure ranks as the lowest quarterly Capital Expenditures since Q1 2024.
  • Year over year, Capital Expenditures gained in five of the last seven quarters, with growth averaging 101.3%.
  • The high point for year-over-year Capital Expenditures in five years was Q1 2022 (growth of 663.4%); the low point was Q1 2024 (a decline of 99.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $713,000 (Q1 2026), $574,000 (Q4 2025) and $674,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,130.97 Bn 1,099.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 614.97 Bn 533.50 Bn 17.26 Bn 1.32 Bn
3 AbbVie 505.56 Bn 478.67 Bn 12.70 Bn 322.00 Mn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.80 Bn 261.79 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.62 Bn 235.31 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.78 Bn 191.18 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 189.91 Bn 164.11 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Bicycle Therapeutics 256.53 Mn -2.09 Bn - 265,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 265,000.00
Mar 31, 2026 713,000.00
Dec 31, 2025 574,000.00
Sep 30, 2025 674,000.00
Jun 30, 2025 498,000.00
Mar 31, 2025 604,000.00
Dec 31, 2024 368,000.00
Sep 30, 2024 435,000.00
Jun 30, 2024 420,000.00
Mar 31, 2024 12,000.00
Dec 31, 2023 51,000.00
Sep 30, 2023 502,000.00
Jun 30, 2023 277,000.00
Mar 31, 2023 2.10 Mn
Dec 31, 2022 1.45 Mn
Sep 30, 2022 2.98 Mn
Jun 30, 2022 9.80 Mn
Mar 31, 2022 4.76 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 169,000.00
API Access

Bicycle Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCYC&period=max&api_key=YOUR_API_KEY